Filipa Lynce, MD, director of Dana-Farber's Inflammatory Breast Program provides an update on ongoing IBC research at the Dana-Farber Inflammatory Breast Cancer Program 5th Annual Patient Forum in April 2022.
Dr. Lynce's presentation includes topics such as why research projects dedicated to IBC are important, redefining IBC diagnostic criteria, ongoing research to optimize clinical care for patients with IBC, and clinical trials designed to address novel targets in IBC.
For more information about Dana-Farber's Inflammatory Breast Cancer Program, please visit us at https://www.dana-farber.org/inflammatory-breast-cancer-program.